Login / Signup

CXCR4 mutational status does not impact outcomes in patients with Waldenström macroglobulinemia treated with proteasome inhibitors.

Jorge J CastilloJoshua N GustineKirsten MeidCatherine A FlynnMaria G DemosMaria L GuerreraCristina JimenezAmanda KofidesXia LiuManit MunshiNicholas TsakmaklisChristopher J PattersonLian XuGuang YangZachary R HunterSteven P Treon
Published in: American journal of hematology (2020)
Keyphrases
  • cell migration
  • type diabetes
  • adipose tissue
  • skeletal muscle
  • glycemic control
  • weight loss